Allen, Jason
Pellois, Jean-Philippe
Funding for this research was provided by:
National Institutes of Health (R01GM110137)
Cancer Prevention and Research Institute of Texas (RP190655)
Article History
Received: 23 May 2022
Accepted: 13 September 2022
First Online: 25 September 2022
Competing interests
: J.P.P. is an inventor on the patent US 9,662,404 B2 relating to d(X)TAT reagents and a co-founder of TANA Therapeutics, a company based in this cell delivery technology. J.A. declares no conflict of interest.